Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Thousand yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In the biomaterials business, revenue and profit increased due to the acquisition of new customers, deeper business with existing customers, the expansion of the service area through the Nagoya CE Center, and higher volumes handled. In the resource recycling business, the company pursued price revisions and the development of new customers, while higher labor costs associated with staff increases and pay raises affected profit. In the other businesses, higher labor costs resulting from staff increases and pay raises, undertaken in anticipation of expanded orders in the future, affected profit.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥5,124 million (YoY +5.1%) |
| Operating profit | ¥483 million (YoY -4.1%) |
| Ordinary income | ¥448 million (YoY -10.0%) |
| Profit attributable to owners of the parent | ¥340 million (YoY -7.4%) |
| Net income per share | ¥29.40 |
| Equity ratio | End of the current fiscal period 45.4 / End of previous period 44.8 |
| Total assets | ¥14,089 million |
| Net assets | ¥6,393 million |
| Cash flows from operating activities | 771,574 Thousand yen |
| Cash flows from investing activities | -471,489 Thousand yen |
| Cash flows from financing activities | 34,790 Thousand yen |
| Cash and cash equivalents at end of period | 1,345,054 Thousand yen |
| Full-year earnings forecast | Net Sales ¥10,823 million (YoY +8.1%) / Operating profit ¥1,287 million (YoY +9.6%) / Ordinary income ¥1,255 million (YoY +6.9%) / Net income ¥891 million (YoY +0.1%) |
| Annual Dividend Forecast | ¥30 → ¥32（+6.7%） |
| Segment revenue | Biomaterials Business 3,779,742 Thousand yen (YoY +6.2%) / Resource-Circulation Business 831,321 Thousand yen (YoY +1.8%) / Other businesses 693,844 Thousand yen (YoY +1.0%) |
| Segment profit | Biomaterials Business 454,621 Thousand yen (YoY +0.8%) / Resource-Circulation Business 22,182 Thousand yen (YoY -37.8%) / Other businesses 13,823 Thousand yen (YoY -42.8%) |
| Depreciation and amortization | 382,571 Thousand yen |
| Impairment loss | None (impairment loss on fixed assets) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of property, plant and equipment 93,367 Thousand yen / Extraordinary loss Loss on disposal of fixed assets 2,837 Thousand yen |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Availability of Supplementary Financial Results Materials | Held |
| Availability of Financial Results Briefing | Available (participants not specified) |
| Issued Shares at Period-End | 11,779,600 |
| Treasury Shares at Period-End | 171,108 |
| Factors Behind Changes in Business Performance | In the biomaterials business, revenue and profit increased due to the acquisition of new customers, deeper business with existing customers, the expansion of the service area through the Nagoya CE Center, and higher volumes handled. In the resource recycling business, the company pursued price revisions and the development of new customers, while higher labor costs associated with staff increases and pay raises affected profit. In the other businesses, higher labor costs resulting from staff increases and pay raises, undertaken in anticipation of expanded orders in the future, affected profit. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the biomaterials business, the acquisition of new customers, deeper business with existing customers, and the expansion of the service area through the Nagoya CE Center contributed to higher revenue. In the resource recycling and other businesses, higher labor costs associated with staff increases and pay raises affected profit.